FDA wants more TAXUS IV data

Angiotech (ANPI; TSE:ANP) partner Boston Scientific (BSX) said the FDA requested additional data to support an IDE to begin the TAXUS IV pivotal trial of a coronary stent coated with slow-release pacl...